Cargando…
Microbiota-directed biotherapeutics: considerations for quality and functional assessment
Mounting evidence points to causative or correlative roles of gut microbiome in the development of a myriad of diseases ranging from gastrointestinal diseases, metabolic diseases to neurological disorders and cancers. Consequently, efforts have been made to develop and apply therapeutics targeting t...
Autores principales: | Fekete, Emily Ef, Figeys, Daniel, Zhang, Xu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10012963/ https://www.ncbi.nlm.nih.gov/pubmed/36896938 http://dx.doi.org/10.1080/19490976.2023.2186671 |
Ejemplares similares
-
Intestinal microbiota: a novel perspective in colorectal cancer biotherapeutics
por: Ding, Chenbo, et al.
Publicado: (2018) -
Gut microbiota: next frontier in understanding human health and development of biotherapeutics
por: Prakash, Satya, et al.
Publicado: (2011) -
Trends in industrialization of biotherapeutics: a survey of product characteristics of 89 antibody-based biotherapeutics
por: Martin, Kyle P., et al.
Publicado: (2023) -
Biomarkers for nonclinical infusion reactions in marketed biotherapeutics and considerations for study design
por: Mease, Kirsten M., et al.
Publicado: (2017) -
The Emerging Biotherapeutic Agent: Akkermansia
por: Kalia, Vipin Chandra, et al.
Publicado: (2021)